Allspring Global Investments Holdings, LLC Morphic Holding, Inc. Transaction History

Allspring Global Investments Holdings, LLC

$62.1 Billion
Q3 2024

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 27, 2023	BUY	$21.33 - $59.42 $62,219 - $173,328	2,917 New	2,917 $66,000
Q2 2023 Jul 18, 2023	BUY	$34.33 - $62.11 $78,821 - $142,604	2,296 Added 547.97%	2,715 $155,000
Q1 2023 Apr 13, 2023	SELL	$26.01 - $48.69 $22,160 - $41,483	-852 Reduced 67.03%	419 $15,000
Q4 2022 Jan 23, 2023	SELL	$24.14 - $30.37 $675 - $850	-28 Reduced 2.16%	1,271 $0
Q2 2022 Jul 25, 2022	SELL	$19.74 - $43.01 $165,677 - $360,982	-8,393 Reduced 86.6%	1,299 $28,000
Q1 2022 May 02, 2022	SELL	$36.25 - $52.02 $16,167 - $23,200	-446 Reduced 4.4%	9,692 $389,000
Q4 2021 Jan 28, 2022	BUY	$43.27 - $65.72 $438,671 - $666,269	10,138 New	10,138 $480,000

Others Institutions Holding MORF

# of Institutions

Shares Held

4.7M

Call Options Held

Put Options Held

View Full List

About Morphic Holding, Inc.

Ticker MORF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,477,100
Market Cap $2.19B
Description
Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, metabolic diseases, as well as fibrosis and cancer. Its lead product candidates are MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation that is in Phase 1 clinical ...

More about MORF

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Allspring Global Investments Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allspring Global Investments Holdings, LLC with notifications on news.

Account